Transplantation of positively selected autologous blood CD34+ progenitor cells or unmanipulated PBSC - Comparison of haematologic recovery

被引：0
|
作者：
Nemet, D [1 ]
Batinic, D [1 ]
Uzarevic, B [1 ]
Skodlar, J [1 ]
Petrovecki, M [1 ]
Bogdanic, V [1 ]
Mrsic, M [1 ]
Maravic, N [1 ]
Sucic, M [1 ]
Golubic, B [1 ]
Bojanic, I [1 ]
Kalenic, S [1 ]
Labar, B [1 ]
机构：
[1] UNIV HOSP,CTR REBRO,ZAGREB,CROATIA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：929 / 929
页数：1
相关论文
共 50 条
  • [21] Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation
    J Friedman
    HM Lazarus
    ON Koç
    Bone Marrow Transplantation, 2000, 26 : 831 - 836
  • [22] Transplantation of positively selected allogeneic blood CD34(+) cells.
    Brugger, W
    Scheding, S
    Subklewe, M
    Faul, C
    Halene, S
    Brandes, A
    Wiesmann, A
    Weiss, B
    Heimfeld, S
    Einsele, H
    Kanz, L
    BLOOD, 1996, 88 (10) : 2383 - 2383
  • [23] Autologous and allogeneic transplantation with peripheral blood CD34+ cells:: a pediatric experience
    Watanabe, T
    Kawano, Y
    Watanabe, A
    Takaue, Y
    HAEMATOLOGICA, 1999, 84 (02) : 167 - 176
  • [24] Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma
    R Abonour
    KM Scott
    LA Kunkel
    MJ Robertson
    R Hromas
    V Graves
    EN Lazaridis
    L Cripe
    V Gharpure
    CM Traycoff
    B Mills
    EF Srour
    K Cornetta
    Bone Marrow Transplantation, 1998, 22 : 957 - 963
  • [25] Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma
    Abonour, R
    Scott, KM
    Kunkel, LA
    Robertson, MJ
    Hromas, R
    Graves, V
    Lazaridis, EN
    Cripe, L
    Gharpure, V
    Traycoff, CM
    Mills, B
    Srour, EF
    Cornetta, K
    BONE MARROW TRANSPLANTATION, 1998, 22 (10) : 957 - 963
  • [26] CD34+selected autologous peripheral blood stem cell transplantation (CD34+/ASCT) for multiple sclerosis
    Carreras, E
    Saiz, A
    Marín, P
    Martínez, C
    Rovira, M
    Villamor, N
    Aymerich, M
    Lozano, M
    Fernández-Avilés, F
    Urbano-Ispizua, A
    Berenguer, J
    Arbizu, T
    Montserrat, E
    Graus, F
    BONE MARROW TRANSPLANTATION, 2003, 31 : S16 - S16
  • [27] Autologous CD34+selected peripheral blood stem cell transplantation (CD34+/PBSCT) for multiple sclerosis
    Carreras, E
    Saiz, A
    Graus, F
    Marín, P
    Martínez, C
    Rovira, M
    Urbano-Ispizua, A
    Arbizu, T
    Casanova, B
    Mercader, JM
    Mazzara, R
    Merino, A
    Tolosa, E
    Montserrat, E
    BLOOD, 1999, 94 (10) : 398B - 398B
  • [28] High-dose therapy in patients with Hodgkin's disease: the use of selected CD34+ cells is as safe as unmanipulated peripheral blood progenitor cells
    AK Blystad
    H Holte
    S Kvaløy
    E Smeland
    J Delabie
    G Kvalheim
    Bone Marrow Transplantation, 2001, 28 : 849 - 857
  • [29] Cytomegalovirus infection following transplantation of autologous CD34-selected progenitor cells
    Schiller, GJ
    Vescio, R
    Berenson, J
    BLOOD, 2000, 96 (03) : 1194 - 1194
  • [30] High-dose therapy in patients with Hodgkin's disease:: the use of selected CD34+ cells is as safe as unmanipulated peripheral blood progenitor cells
    Blystad, AK
    Holte, H
    Kvaloy, S
    Smeland, E
    Delabie, J
    Kvalheim, G
    BONE MARROW TRANSPLANTATION, 2001, 28 (09) : 849 - 857
12345